Abstract:The Ganoderma meroterpenoids are a growing class of natural products with architectural complexity, and exhibit a wide range of biological activities. Here, we report an enantioselective total synthesis of the Ganoderma meroterpenoid (‒)-lucidumone. The synthetic route features several key transformations, including a) a Cu-catalyzed enantioselective silicon-tethered intramolecular Diels-Alder cycloaddition to construct the highly functionalized bicyclo[2.2.2]octane moiety; b) Brønsted acid promoted tandem O-deprotection/Prins cyclization/Cycloetherification sequence followed by oxidation to install concurrently the tetrahydrofuran and the fused indanone framework; c) Fleming-Tamao oxidation to generate the secondary hydroxyl; d) an iron-catalyzed Wacker-type oxidation of hindered vinyl group to methyl ketone.

What problem does this paper attempt to address?

The problem this paper attempts to address is the enantioselective total synthesis of (‒)-lucidumone. Lucidumone is a complex natural product isolated from Ganoderma lucidum, with various biological activities, particularly strong inhibitory effects on COX-1 and COX-2, making it a potential lead compound for anti-inflammatory drugs. However, its complex polycyclic structure and multiple stereocenters make its synthesis highly challenging. To achieve this goal, the authors designed an efficient synthetic route that includes the following key steps: 1. **Copper-catalyzed enantioselective intramolecular Diels-Alder reaction**: Used to construct a highly functionalized bicyclo[2.2.2]octane framework. 2. **Brønsted acid-promoted tandem O-deprotection/Prins cyclization/cycloetherification reaction**: Followed by oxidation, simultaneously installing the tetrahydrofuran and fused indanone frameworks. 3. **Fleming-Tamao oxidation**: To generate a secondary alcohol. 4. **Iron-catalyzed Wacker-type oxidation**: To oxidize the hindered alkene to a methyl ketone. Through these key steps, the authors successfully achieved the enantioselective total synthesis of (‒)-lucidumone, providing an important foundation for subsequent pharmacological research and drug development.

Enantioselective total synthesis of (‒)-lucidumone enabled by tandem prins cyclization/cycloetherification sequence

Total Synthesis of Lucidumone: Attempted Shortcuts, Dead Ends and Lessons Learnt

Total synthesis of spiro Ganoderma meroterpenoids spiroapplanatumines B, D, F, and H

Enantioselective Total Synthesis of Berkeleyone A and Preaustinoids

Enantioselective Total Synthesis of (−)-Hamigeran F and Its Rearrangement Product

Enantioselective Total Syntheses of (−)‐rhazinilam, (−)‐leucomidine B, and (+)‐leuconodine F

Enantioselective Total Synthesis of (+)-Plumisclerin A.

Evolution of a Strategy for the Unified, Asymmetric Total Syntheses of DMOA-Derived Spiromeroterpenoids

Enantioselective Total Syntheses of Leuconolam-Leuconoxine-Mersicarpine Group Monoterpene Indole Alkaloids

Enantioselective Total Synthesis of (+)-Sieboldine A and Analogues Thereof

Enantioselective Total Syntheses of Grayanane Diterpenoids: (-)-Grayanotoxin III, (+)-Principinol E, and (-)-Rhodomollein XX

A New Organocatalytic Desymmetrization Reaction Enables the Enantioselective Total Synthesis of Madangamine E

Enantioselective Total Synthesis of Lycoposerramine-Z Using Chiral Phosphoric Acid Catalyzed Intramolecular Michael Addition

Enantioselective Hydrofunctionalization of Cyclobutenones: Total Synthesis of gem‐Dimethylcyclobutane Natural Products

Enantiospecific Semisynthesis of Puupehedione-Type Marine Natural Products

Asymmetric Total Synthesis of (−)-Lingzhiol Via a Rh-catalysed [3+2] Cycloaddition

Collective Total Synthesis of (-)-lundurines A-C

Total Syntheses of Lycoposerramine-V and 5-Epi-lycoposerramine-v.

The Total Synthesis of (−)-Strempeliopine Via Palladium-Catalyzed Decarboxylative Asymmetric Allylic Alkylation

Unified Enantiospecific Synthesis of Drimane Meroterpenoids Enabled by Enzyme Catalysis and Transition Metal Catalysis

Enantioselective Total Syntheses of Pallambins A–D